Online access and exploration: https://cardiomap.elixir-luxembourg.org
Disease IDs: MONDO:0005252, MESH:D006333, DOID:6000
Development status: First version is complete and published
Construction tool: CellDesigner
Sustainable support: MINERVA Platform
Funding: ERA PerMed, FNR INTER, Reference Number ERAPERMED2019-237
How to cite: Berndt, et al. Circulation. 2021. PMID: 34762513.
Contacts: Nikolaus Berndt, Charité – Universitätsmedizin Berlin, Germany, nikolaus.berndt(at)charite.de; Irina Balaur, University of Luxembourg, Belvaux, Luxembourg, irina.balaur(at)uni.lu
The CardioMap project is developed within HeartMed, an ICT platform for combining preclinical and clinical information for enhancing translational medicine and patient-specific modelling in cardiovascular diseases
The cardiomap focuses on metabolic and signalling pathways important for understanding different phenotypes of heart failure:
This project was supported under the framework of ERA PerMed, FNR INTER, Reference Number ERAPERMED2019-237.
Berndt N, Eckstein J, Wallach I, Nordmeyer S, Kelm M, Kirchner M, Goubergrits L, Schafstedde M, Hennemuth A, Kraus M, Grune T, Mertins P, Kuehne T, Holzhütter HG. CARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve Diseases. Circulation. 2021 Dec 14;144(24):1926-1939. doi: 10.1161/CIRCULATIONAHA.121.055646. Epub 2021 Nov 11. PMID: 34762513.